FDA Inspection 1242447 — Humacyte Global, Inc
The FDA completed an inspection of Humacyte Global, Inc on June 17, 2024 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 17, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Sponsor, Contract Research Organization